PATENT CLAIM ANALYSIS

Application Number: 15893341
Application Type: Utility
Filing Date: 2018-02
Publication Date: 2018-11
Patent Classification: ["546", "193000"]

Abstract:
Compounds of formula I that modulate or inhibit the enzymatic activity of indoleamine 2,3-dioxygenase, pharmaceutical compositions including such compounds and methods of treating diseases, conditions or disorders utilizing such compounds and compositions.

Claim (Index 2):
A compound of formula II: wherein:\n X is N; \n X 1  is selected from CH2, O, S or NR 1 , where R 1  is H or C1-C3 alkyl; \n Y 1  is N or C; \n R 2  and R 3  independently is H or C1-C2-alkyl or together with the carbon to which they are attached to form is C3-C4 cycloalkyl; \n X 2  is selected from O, S, NH; \n R 5  is optionally substituted C1-C6 alkyl, optionally substituted C2-C6 alkenyl, optionally substituted C2-C6 alkynyl, optionally substituted C3-C7 cycloalkyl, or optionally substituted C4-C7 cycloalkenyl; optionally substituted aryl, optionally substituted C7-C10 alkylaryl, optionally substituted C7-C10 alkoxyaryl, optionally substituted C3-C10 heteroaryl, optionally substituted C3-10-alkyl heteroaryl or C3-C8 heterocycle.

Metadata:
- Claim Count in Document: 28.0
- Percentile: 88.0
- Lexical Diversity: 1.2963
- Patent Class: 546.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['13780510', '11641284', '15613361', '14795466', '15698788']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7373729896906319
- 35 USC 102 Novelty (BERT): 0.4923870166551399
- Combined Prediction Score: 0.7128743923870827
- Mean Citation Score: 242.17147600000004
- Max Citation Score: 245.82295
- Similarity Product: 207.34568468590385

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test